
HLA-DR Antibody (LN3) is a mouse monoclonal IgG2b kappa light chain antibody, designed to target the HLA-DR protein, also known as the Major Histocompatibility Complex class II (MHC II) cell surface receptor. HLA-DR plays a critical role in the immune system by presenting processed antigenic peptides to CD4+ helper T cells, thereby initiating and regulating immune responses. This function is essential for the body′s ability to recognize and defend against pathogens, as well as in the development of immune tolerance. Anti-HLA-DR antibody (LN3) is raised against activated peripheral blood mononuclear cells of human origin. HLA-DR (LN3) antibody is recommended for use in various applications, including western blotting (WB), immunoprecipitation (IP), and flow cytometry (FCM), demonstrating robust reactivity with human HLA-DR. Understanding and targeting HLA-DR is crucial in research areas such as autoimmune diseases, transplantation, and immunotherapy, where modulation of immune responses is necessary. Anti-HLA-DR antibody (LN3) enables researchers to effectively study the expression and function of HLA-DR, contributing to advancements in immunological studies and therapeutic developments.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Contains Mercury: All HRP conjugates (including bundle forms) contain thiomersal, a mercury compound. Do not dispose in trash. Dispose as hazardous chemical waste according to local, state and federal regulations.
Download thiomersal SDS
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
HLA-DR Antibody (LN3) | sc-59252 | 200 µg/ml | $322.00 | |||
HLA-DR Antibody (LN3): m-IgG Fc BP-HRP Bundle | sc-539123 | 200 µg Ab; 10 µg BP | $361.00 | |||
HLA-DR Antibody (LN3): m-IgG2b BP-HRP Bundle | sc-549732 | 200 µg Ab; 10 µg BP | $361.00 |